Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients
2021 · Lipids in Health and Disease · 25 citations
https://doi.org/10.1186/s12944-021-01441-9